These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

231 related articles for article (PubMed ID: 8989829)

  • 1. Factor XIII in ulcerative leg disease: background and preliminary clinical results.
    Wozniak G; Dapper F; Alemany J
    Semin Thromb Hemost; 1996; 22(5):445-50. PubMed ID: 8989829
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Possible role of coagulation factor XIII in the pathogenesis of venous leg ulcers.
    Peschen M; Thimm C; Weyl A; Weiss JM; Kurz H; Augustin M; Simon JC; Schöpf E; Vanscheidt W
    Vasa; 1998 May; 27(2):89-93. PubMed ID: 9612112
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Factor XIII: experimental and clinical results in diabetic foot ulcer].
    Wozniak G; Noll T; Bott U; Hehrlein FW
    Zentralbl Chir; 1999; 124 Suppl 1():73-7. PubMed ID: 10436533
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Factor XIII-deficiency in the blood of venous leg ulcer patients.
    Vanscheidt W; Hasler K; Wokalek H; Niedner R; Schöpf E
    Acta Derm Venereol; 1991; 71(1):55-7. PubMed ID: 1676216
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Topical treatment of chronic venous ulcers with sucralfate: a placebo controlled randomized study.
    Tumino G; Masuelli L; Bei R; Simonelli L; Santoro A; Francipane S
    Int J Mol Med; 2008 Jul; 22(1):17-23. PubMed ID: 18575771
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Factor XIII in chronic inflammatory bowel diseases.
    Lorenz R; Olbert P; Born P
    Semin Thromb Hemost; 1996; 22(5):451-5. PubMed ID: 8989830
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Short-contact topical tretinoin therapy to stimulate granulation tissue in chronic wounds.
    Paquette D; Badiavas E; Falanga V
    J Am Acad Dermatol; 2001 Sep; 45(3):382-6. PubMed ID: 11511834
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effectiveness and safety of a novel gel dressing in the management of neuropathic leg ulcers in diabetic patients: a prospective double-blind randomized trial.
    Abbruzzese L; Rizzo L; Fanelli G; Tedeschi A; Scatena A; Goretti C; Macchiarini S; Piaggesi A
    Int J Low Extrem Wounds; 2009 Sep; 8(3):134-40. PubMed ID: 19703948
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Some effects of a topical collagen-based matrix on the microcirculation and wound healing in patients with chronic venous leg ulcers: preliminary observations.
    Wollina U; Schmidt WD; Krönert C; Nelskamp C; Scheibe A; Fassler D
    Int J Low Extrem Wounds; 2005 Dec; 4(4):214-24. PubMed ID: 16286373
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Autologous platelet-rich fibrin matrix as cell therapy in the healing of chronic lower-extremity ulcers.
    O'Connell SM; Impeduglia T; Hessler K; Wang XJ; Carroll RJ; Dardik H
    Wound Repair Regen; 2008; 16(6):749-56. PubMed ID: 19128245
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Effectiveness of mesoglycan topical treatment of leg ulcers in subjects with chronic venous insufficiency].
    La Marca G; Pumilia G; Martino A
    Minerva Cardioangiol; 1999 Sep; 47(9):315-9. PubMed ID: 10630070
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Management of leg ulcers in patients with rheumatoid arthritis or systemic sclerosis: the importance of concomitant arterial and venous disease.
    Hafner J; Schneider E; Burg G; Cassina PC
    J Vasc Surg; 2000 Aug; 32(2):322-9. PubMed ID: 10917993
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Comparison of the effectiveness and cost of treatment with humid environment as compared to traditional cure. Clinical trial on primary care patients with venous leg ulcers and pressure ulcers].
    Capillas Pérez R; Cabré Aguilar V; Gil Colomé AM; Gaitano García A; Torra i Bou JE
    Rev Enferm; 2000 Jan; 23(1):17-24. PubMed ID: 10788945
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Treatment of venous leg ulcers with Dermagraft.
    Omar AA; Mavor AI; Jones AM; Homer-Vanniasinkam S
    Eur J Vasc Endovasc Surg; 2004 Jun; 27(6):666-72. PubMed ID: 15121121
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Management of mixed arterial and venous leg ulcers.
    Humphreys ML; Stewart AH; Gohel MS; Taylor M; Whyman MR; Poskitt KR
    Br J Surg; 2007 Sep; 94(9):1104-7. PubMed ID: 17497654
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Medical and surgical therapy for advanced chronic venous insufficiency.
    Word R
    Surg Clin North Am; 2010 Dec; 90(6):1195-214. PubMed ID: 21074036
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Factor XIII in the treatment of postoperative refractory wound-healing disorders. Results of a controlled study].
    Mishima Y; Nagao F; Ishibiki K; Matsuda M; Nakamura N
    Chirurg; 1984 Dec; 55(12):803-8. PubMed ID: 6394228
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Treatment guidelines for venous leg ulcers: causal therapy initiation and local wound treatment].
    Hafner J; Brunner U; Burg G
    Ther Umsch; 1996 Apr; 53(4):304-8. PubMed ID: 8658354
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Studies on zinc in wound healing.
    Agren MS
    Acta Derm Venereol Suppl (Stockh); 1990; 154():1-36. PubMed ID: 2275309
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Evaluation of vascular and metabolic deficiency in patients with large leg ulcers.
    Balaji P; Mosley JG
    Ann R Coll Surg Engl; 1995 Jul; 77(4):270-2. PubMed ID: 7574318
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.